ATR and acute lymphoblastic leukemia: In B-ALL cells, as with AML, the pol 1 inhibitor CX5461 activates the ATR pathway and mediates G2 checkpoint arrest, and thus induced apoptosis synergistically in combination with VE-822 (45), providing another alternative combination strategy through exacerbation of replication stress.